Nonalcoholic Steatohepatitis: Epidemiology, Screening, Risk Assessment, Diagnosis, and Management

  • Author: Philip N. Newsome, PhD, FRCPE (More Info)
  • Editor In Chief: Quentin M. Anstee, BSc, MB BS, PhD, MRCP(UK), FRCP
  • Last Reviewed: 8/23/19 (What's New)

Summary

  • Precise data are limited on the prevalence of NAFLD and NASH due to varying methods for diagnosis and lack of routine record keeping
    • Determining NASH prevalence is challenged by the need for diagnostic biopsy
  • The estimated global prevalence of NAFLD is 25.24%, with rates varying among different regions[Younossi 2016]

    Action required